Impact of intravitreal aflibercept dosing regimens in treatment-naïve patients with neovascular age-related macular degeneration: 2-year results of RAINBOW.
作者:
主题词
老年人(Aged);老年人, 80以上(Aged, 80 and over);血管生成抑制剂(Angiogenesis Inhibitors);脉络膜新生血管化(Choroidal Neovascularization);女(雌)性(Female);随访研究(Follow-Up Studies);人类(Humans);玻璃体内注射(Intravitreal Injections);男(雄)性(Male);受体, 血管内皮生长因子(Receptors, Vascular Endothelial Growth Factor);重组融合蛋白质类(Recombinant Fusion Proteins);体层摄影术, 光学相干(Tomography, Optical Coherence);治疗结果(Treatment Outcome);血管内皮生长因子A(Vascular Endothelial Growth Factor A);视敏度(Visual Acuity);湿性黄斑变性(Wet Macular Degeneration)
DOI
10.1186/s12886-020-01468-z
PMID
32450838
发布时间
2021-04-05
- 浏览15
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文